/
Endometrial & Ovarian Cancer   in Lynch Syndrome Endometrial & Ovarian Cancer   in Lynch Syndrome

Endometrial & Ovarian Cancer in Lynch Syndrome - PowerPoint Presentation

PeacefulPassion
PeacefulPassion . @PeacefulPassion
Follow
343 views
Uploaded On 2022-07-28

Endometrial & Ovarian Cancer in Lynch Syndrome - PPT Presentation

Henny Lukman Consultant Obstetrician amp Gynaecologist Cancer General Population Risk Syndrome Risk Mean age of onset 10 year survival England amp Wales Endometrium 3 4060 4855 ID: 930367

risk cancer ovarian years cancer risk years ovarian 1000 endometrial data contraceptive surgery early amp difference evidence oral changed

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Endometrial & Ovarian Cancer in Ly..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Endometrial & Ovarian Cancer in Lynch Syndrome

Henny Lukman

Consultant Obstetrician & Gynaecologist

Slide2

Slide3

Cancer

General Population Risk

Syndrome Risk

Mean age of onset10 year survival (England & Wales)Endometrium3%40-60%48-5578%Ovarian1.4%10-20%42-4635%

RCOG 2015

Slide4

Screening ?

Endometrial Cancer

Ovarian cancer

Evidence for screeningNo (RCOG- part of research only)No difference in early stage pick upSymptomsAbnormal bleedingNone in early stages, often vagueUltrasoundTransvaginalTransvaginalOther tests

Hysteroscopy, biopsy

CA125

How often

?

?

Slide5

Symptoms

Endometrial cancer: abnormal bleeding

Ovarian cancer : very vague in early stages

pain, bloating

Slide6

Slide7

Slide8

Slide9

Slide10

Slide11

Key hole surgery

Open surgery

Risk Reducing Surgery

Slide12

Hormone Replacement Therapy

Recommended until the age of 50

Oestrogen only

Most publicised risk only apply to women over 50.

Slide13

The evidence – NICE 2015

Per 1000 women

<60 y.o.Baseline

Current user

>5 years since stopping

Coronary heart disease

UK over 7.5 years: 26.3 per 1000 

1

E only --6 fewer

E only --6 fewer

E+P ---5 more

E+P ---4 more

Stroke

UK over 7.5 years: 11.3 per 1000

E only --0

E only –1 more

E+P ---6 more

E+P ---4 more

Breast cancer

UK over 7.5 years: 22.48 per 1000

E only --4 fewer

E only --5 fewer

E+P ---5 more

E+P ---8 more

Fragility fractures

Baseline rate 69 per 1000

23 fewer

No data

Ovarian

1 more per 1000 after 5 years use

Little difference between E alone or E+P

No data

Dementia

No data

Slide14

Slide15

Risks that can be changed

-Endometrial cancer

Risk

 RiskIncreased body weightCombined oral contraceptive pillLow of physical activitiesRegular exerciseRed meatEat more vegetable(HRT)Coffee, tea (especially green)Contraceptive

coil

Aspirin

(HRT)

Slide16

Risks that can be changed

-Ovarian cancer

Risk

 RiskSmokingBreastfeeding more than 6 months?have more pregnancies?OverweightCombined oral contraceptive pillEat more vegetable

Slide17

Slide18